enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. AstraZeneca's Imfinzi gets FDA priority review for type of ...

   www.aol.com/news/astrazenecas-imfinzi-gets-fda...

   AstraZeneca's application was based on positive late-stage data that showed the drug improved overall survival and progression-free survival in patients with a type of lung cancer, whose disease ...

3. AstraZeneca stock drops after lung cancer drug trial setback

   www.aol.com/news/astrazeneca-shares-drop-lung...

   (Reuters) -London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that its experimental precision drug did not significantly ...

4. AstraZeneca shares drop as lung cancer trial update lags ...

   www.aol.com/news/astrazeneca-shares-drop-lung...

   AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company's shares fell as much as 6% as analysts said the benefits may not ...

5. AstraZeneca's Investigational Cancer Drug Disappoints In Late ...

   www.aol.com/astrazenecas-investigational-cancer...

   Monday, AstraZeneca Plc (NASDAQ:AZN) shared detailed results from the TROPION-Lung01 Phase 3 of datopotamab deruxtecan (Dato-DXd) compared to docetaxel, the current standard of care chemotherapy ...

6. AstraZeneca says lung cancer drug trial shows no significant ...

   www.aol.com/news/astrazeneca-says-lung-cancer...

   The trial compared the two treatments -- AstraZeneca's drug and chemotherapy -- of patients whose non-small cell lung cancer had returned after one or two prior treatment attempts.

7. Savolitinib - Wikipedia

   en.wikipedia.org/wiki/Savolitinib

   It is being investigated for the treatment of cancer by AstraZeneca. [1] It is in phase II clinical trials for adenocarcinoma, non-small cell lung cancer, and renal cell carcinoma. [2] It has been given conditional approval for these indication in China. [3]

8. AstraZeneca's Imfinzi fails in late-stage trial to treat ...

   www.aol.com/news/astrazenecas-imfinzi-fails...

   The trial, known as ADJUVANT BR.31 Phase III, sought to evaluate Imfinzi in the adjuvant treatment of 1,415 patients with an early stage of non-small-cell lung cancer following complete tumour ...

9. US FDA approves AstraZeneca's non-small cell lung cancer ...

   www.aol.com/news/us-fda-approves-astrazenecas...

   Earlier today, the company received a priority review from the FDA for the use of Imfinzi in patients with limited-stage small cell lung cancer, causing shares to hit a record high of 130.48 ...